OHSU Cancer Institute, 1 Of Largest In GIST Study And Gleevec
Gleevec, a pill developed in conjunction with the Oregon Health & Science University Cancer Institute is again showing excellent results in preventing a cancer recurrence. [click link for full article]
More: continued here
Filed under: Cancer on April 15th, 2007